Rebecca Mitchell1, Jill McDermid, Mang M Ma, Constance L Chik. 1. Rebecca Mitchell, Constance L Chik, Divisions of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2S2, Alberta, Canada.
Abstract
AIM: To determine the contributions of insulin-like growth factor 1 (IGF-1), cytokines and liver disease severity to bone mineral density in patients pre-transplantation. METHODS: Serum IGF-1, tumor necrosis factor-α (TNFα) and interleukin 6 (IL-6) were measured and the Model for End-Stage Liver Disease (MELD) score calculated in 121 adult patients referred to a single centre for liver transplantation. Bone mineral density (BMD) of the lumbar spine and femoral neck were assessed via dual energy X-ray absorptiometry. Demographics, liver disease etiology, medication use and relevant biochemistry were recorded. RESULTS: A total of 117 subjects were included, with low BMD seen in 68.6%, irrespective of disease etiology. In multivariable analysis, low body mass index (BMI), increased bone turnover and low IGF-1 were independent predictors of low spinal bone density. At the hip, BMI, IGF-1 and vitamin D status were predictive. Despite prevalent elevations of TNFα and IL-6, levels did not correlate with degree of bone loss. The MELD score failed to predict low BMD in this pre-transplant population. CONCLUSION: Osteopenia/osteoporosis is common in advanced liver disease. Low serum IGF-1 is weakly predictive but serum cytokine and MELD score fail to predict the severity of bone disease.
AIM: To determine the contributions of insulin-like growth factor 1 (IGF-1), cytokines and liver disease severity to bone mineral density in patients pre-transplantation. METHODS: Serum IGF-1, tumor necrosis factor-α (TNFα) and interleukin 6 (IL-6) were measured and the Model for End-Stage Liver Disease (MELD) score calculated in 121 adult patients referred to a single centre for liver transplantation. Bone mineral density (BMD) of the lumbar spine and femoral neck were assessed via dual energy X-ray absorptiometry. Demographics, liver disease etiology, medication use and relevant biochemistry were recorded. RESULTS: A total of 117 subjects were included, with low BMD seen in 68.6%, irrespective of disease etiology. In multivariable analysis, low body mass index (BMI), increased bone turnover and low IGF-1 were independent predictors of low spinal bone density. At the hip, BMI, IGF-1 and vitamin D status were predictive. Despite prevalent elevations of TNFα and IL-6, levels did not correlate with degree of bone loss. The MELD score failed to predict low BMD in this pre-transplant population. CONCLUSION:Osteopenia/osteoporosis is common in advanced liver disease. Low serum IGF-1 is weakly predictive but serum cytokine and MELD score fail to predict the severity of bone disease.
Entities:
Keywords:
Bone mineral density; Cytokines; Hepatic osteodystrophy; Insulin-like growth factor-1; MELD score
Authors: J Genesca; A Gonzalez; R Segura; R Catalan; R Marti; E Varela; G Cadelina; M Martinez; J C Lopez-Talavera; R Esteban; R J Groszmann; J Guardia Journal: Am J Gastroenterol Date: 1999-01 Impact factor: 10.864
Authors: C Scheidt-Nave; H Bismar; G Leidig-Bruckner; H Woitge; M J Seibel; R Ziegler; J Pfeilschifter Journal: J Clin Endocrinol Metab Date: 2001-05 Impact factor: 5.958
Authors: Rana Paramvir Sokhi; Abhinandana Anantharaju; Ravi Kondaveeti; Steven D Creech; Khondker K Islam; David H Van Thiel Journal: Liver Transpl Date: 2004-05 Impact factor: 5.799
Authors: Chang Seok Bang; In Soo Shin; Sung Wha Lee; Jin Bong Kim; Gwang Ho Baik; Ki Tae Suk; Jai Hoon Yoon; Yeon Soo Kim; Dong Joon Kim Journal: World J Gastroenterol Date: 2015-04-07 Impact factor: 5.742
Authors: Ahmed O Kaseb; Lianchun Xiao; Manal M Hassan; Young Kwang Chae; Ju-Seog Lee; Jean-Nicolas Vauthey; Sunil Krishnan; Sheree Cheung; Hesham M Hassabo; Thomas Aloia; Claudius Conrad; Steven A Curley; John M Vierling; Prasun Jalal; Kanwal Raghav; Michael Wallace; Asif Rashid; James L Abbruzzese; Robert A Wolff; Jeffrey S Morris Journal: J Natl Cancer Inst Date: 2014-05-09 Impact factor: 13.506